15 minutes delayed
Panbela Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Panbela Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-1.47 | $-1.69 | 13.0 % |
Mar 2024 | 2024-05-15 | $-2.28 | $-1.48 | -54.0 % |
Dec 2023 | 2024-03-26 | $-65.90 | $-24.34 | -170.8 % |
Sep 2023 | 2023-11-09 | $-2.42 | $-2.06 | -17.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Panbela Therapeutics (PBLA) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-1.47, which beat the estimate of $-1.69.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.